awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28072004-2FE9EF29-C4A5-4063-B0FE-C15241A019A4
Q28072004-2FE9EF29-C4A5-4063-B0FE-C15241A019A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28072004-2FE9EF29-C4A5-4063-B0FE-C15241A019A4
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer
P2860
Q28072004-2FE9EF29-C4A5-4063-B0FE-C15241A019A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28072004-2FE9EF29-C4A5-4063-B0FE-C15241A019A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f07bb530edbf5a81ba45e2d4fe1eabc56ba2479
P2860
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer